A phase I/II study of the safety and anti-cancer activity of IV-administered belinostat (PXD101) plus carboplatin (C) or paclitaxel (P), or both in patients with advanced solid tumors
Year: 2007
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: R. Sinha, R. Moliffe, M. Scurr, L. Vidal, S. A. Engelholm, P. Buhl Jensen, A. Normann, S. Li, J. De Bono, U. Lassen
Institutions: Rigshospitalet, Royal Marsden Hospital
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2243735979